EUVIMEDEUVIMED entdecken
Crossref

68 Ga-Labeled LLP2A for PET Imaging of Very Late Antigen-4 in Acute Cardiac Rejection

Huiling Li iD, Yongkang Gai iD, Xiaolin Hou, Qiyue Duan, Ya Wu, Cheng Deng, Yu Long, Li Zhang, Yihan Chen, Xiaoli Lan, Mingxing Xie iD

Molecular Pharmaceutics · 06.07.2026 · 23 (7) · 3760-3768

DOI: 10.1021/acs.molpharmaceut.6c00220 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 03.06.2026. Verfasst von Huiling Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, First Hospital of Shanxi Medical University, Taiyuan 030001, China. Hauptthemen laut MEDLINE: Gallium Radioisotopes, Graft Rejection, Heart Transplantation, Integrin alpha4beta1. Die Arbeit nennt 23 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Science, Technology and Innovation Commission of Shenzhen Municipality, Natural Science Foundation of Hubei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gallium RadioisotopesGraft RejectionHeart TransplantationIntegrin alpha4beta1AnimalsRatsMiceTissue DistributionRats, Inbred LewMalePositron Emission Tomography Computed TomographyRadiopharmaceuticalsPositron-Emission TomographyMice, Inbred C57BLHumans

Stichwörter der Autor:innen

PET/CTacute cardiac rejectionradionuclide molecular imagingvery late antigen-4 (VLA-4)

Substanzen

Gallium RadioisotopesIntegrin alpha4beta1Gallium-68Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Nuclear Medicine, First Hospital of Shanxi Medical University, Taiyuan 030001, China.
  • Department of Ultrasound, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Hubei Province Key Laboratory of Molecular Imaging, Wuhan 430022, China.
  • Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

ORCID-Profile: Huiling Li, Yongkang Gai, Mingxing Xie

Förderung

  • China Postdoctoral Science Foundation
  • Science, Technology and Innovation Commission of Shenzhen Municipality
  • Natural Science Foundation of Hubei Province
  • National Natural Science Foundation of China

Zitieren

APA

Li, H., Gai, Y., Hou, X., Duan, Q., Wu, Y., Deng, C., Long, Y., Zhang, L., Chen, Y., Lan, X., & Xie, M. (2026). 68 Ga-Labeled LLP2A for PET Imaging of Very Late Antigen-4 in Acute Cardiac Rejection. Molecular Pharmaceutics, 23(7), 3760-3768. https://doi.org/10.1021/acs.molpharmaceut.6c00220

Vancouver

Li H, Gai Y, Hou X, Duan Q, Wu Y, Deng C, et al. 68 Ga-Labeled LLP2A for PET Imaging of Very Late Antigen-4 in Acute Cardiac Rejection. Molecular Pharmaceutics. 2026;23(7):3760-3768. doi:10.1021/acs.molpharmaceut.6c00220

BibTeX
@article{Li2026,
  author = {Li, Huiling and Gai, Yongkang and Hou, Xiaolin and Duan, Qiyue and Wu, Ya and Deng, Cheng and Long, Yu and Zhang, Li and Chen, Yihan and Lan, Xiaoli and Xie, Mingxing},
  title = {68 Ga-Labeled LLP2A for PET Imaging of Very Late Antigen-4 in Acute Cardiac Rejection},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  volume = {23},
  number = {7},
  pages = {3760--3768},
  doi = {10.1021/acs.molpharmaceut.6c00220}
}
Kostenlos starten →